⌘K

Home/Filings/4/0001209191-20-007057

4//SEC Filing

Belsky Marc 4

Accession 0001209191-20-007057

CIK 0001645666other

View on SEC.gov Company Profile

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 8:19 PM ET

Size

5.4 KB

Accession

0001209191-20-007057

Insider Transaction Report

Form 4

Period: 2020-02-04

Kezar Life Sciences, Inc.KZR

Chief Financial Officer

Transactions

Purchase
Common Stock
2020-02-04$2.60/sh+15,384$39,998→ 15,384 total

Holdings

Common Stock
(indirect: By Trust)
2,000

Footnotes (1)

[F1]Shares were purchased in a public offering of the Issuer at a public offering price of $2.60.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Kezar Life Sciences, Inc.

CIK 0001645666

Entity typeother

Related Parties

1

filerCIK 0001382629

Filing Metadata

Form type: 4
Filed: Feb 4, 7:00 PM ET
Accepted: Feb 5, 8:19 PM ET
Size: 5.4 KB

View on SEC.gov